- Home
- SPNT vs VCYT Comparison
SPNT vs VCYT Comparison
Compare SPNT & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPNT
- VCYT
- Stock Information
- Founded
- SPNT 2011
- VCYT 2006
- Country
- SPNT Bermuda
- VCYT United States
- Employees
- SPNT N/A
- VCYT N/A
- Industry
- SPNT Property-Casualty Insurers
- VCYT Medical Specialities
- Sector
- SPNT Finance
- VCYT Health Care
- Exchange
- SPNT Nasdaq
- VCYT Nasdaq
- Market Cap
- SPNT 2.2B
- VCYT 2.1B
- IPO Year
- SPNT N/A
- VCYT 2013
- Fundamental
- Price
- SPNT $19.74
- VCYT $24.08
- Analyst Decision
- SPNT Buy
- VCYT Buy
- Analyst Count
- SPNT 3
- VCYT 9
- Target Price
- SPNT $24.00
- VCYT $39.89
- AVG Volume (30 Days)
- SPNT 604.2K
- VCYT 1.9M
- Earning Date
- SPNT 08-04-2025
- VCYT 08-06-2025
- Dividend Yield
- SPNT N/A
- VCYT N/A
- EPS Growth
- SPNT N/A
- VCYT N/A
- EPS
- SPNT 0.96
- VCYT 0.41
- Revenue
- SPNT $2,682,300,000.00
- VCYT $463,393,000.00
- Revenue This Year
- SPNT $5.14
- VCYT $12.55
- Revenue Next Year
- SPNT $7.45
- VCYT $9.79
- P/E Ratio
- SPNT $20.38
- VCYT $57.91
- Revenue Growth
- SPNT N/A
- VCYT 23.42
- 52 Week Low
- SPNT $12.78
- VCYT $19.73
- 52 Week High
- SPNT $21.03
- VCYT $47.32
- Technical
- Relative Strength Index (RSI)
- SPNT 53.71
- VCYT 39.09
- Support Level
- SPNT $19.20
- VCYT $22.61
- Resistance Level
- SPNT $20.00
- VCYT $26.11
- Average True Range (ATR)
- SPNT 0.42
- VCYT 1.01
- MACD
- SPNT 0.06
- VCYT -0.00
- Stochastic Oscillator
- SPNT 78.07
- VCYT 26.22
About SPNT SiriusPoint Ltd.
SiriusPoint Ltd provides property and casualty reinsurance coverage to insurance and reinsurance companies in the United States, Canada, Bermuda, the United Kingdom, and Europe. The company operates through two operating segments: Reinsurance and Insurance & Services. The company's product portfolio consists of reinsurance contracts for property insurance including both residential and commercial properties, workers' compensation, personal automobile, businesses' general liability insurance, professional liability insurance to protect professional advisors and service providers, agriculture insurance, and mortgage insurance. The majority of the revenue is generated from its Insurance & Services segment.
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.